PHARMAVOX
Board
3 directors, no change since January 2026Director (not named in the articles), permanent representative
since 01-05-2019
term without a fixed end
earlier manager, until 01-05-2019
listed in the 2026 annual accounts, filed on 16-10-2026
Director (not named in the articles), permanent representative
since 01-05-2019
term without a fixed end
earlier manager, until 01-05-2019
listed in the 2026 annual accounts, filed on 16-10-2026
Director (not named in the articles)
since 01-05-2019
earlier manager, until 01-05-2019
listed in the 2026 annual accounts, filed on 16-10-2026
Permanent representatives 2
Mandates through the years
3 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Manager, appointed by deed of 16-10-2015, until 01-05-2019
- Director (not named in the articles), since before 01-05-2019
-
- Manager, appointed by deed of 16-10-2015, until 01-05-2019
- Director (not named in the articles), since before 01-05-2019
-
- Director (not named in the articles), from 25-04-2019 to date
- Manager, until 01-05-2019
With Starter you also see 3 former office holders in the mandate history.
See the plans →
Control
Founders
, ,
and 2 others
This company
PHARMAVOX
Equity €6.4m
Loss €475,741 in 2026
Capital
- Contribution
- €9,210,000
- Shares
- 19,210
- Contribution per share
- €479
- Equity per share
- €333 in 2026
- Source
- 2026 annual accounts
Articles of association
deed of 17-05-2019 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 21 September at 10:00
Shareholders
At incorporation
deed of 19-12-2011 ↗
- 11,594 shares · “pleine propriété actions BYMITCH”
- 1,904 shares · “pleine propriété actions BYMITCH”
- 1,904 shares · “pleine propriété actions BYMITCH”
- 1,904 shares · “pleine propriété actions BYMITCH”
- 1,904 shares · “pleine propriété actions BYMITCH”
Capital transactions
Capital over time
- 08-08-2019 Converted to available equity · €10,000,000
- 17-05-2019 Converted to unavailable equity
- 19-12-2011 Incorporation · €19,210,000 · 19,210 shares